Elected: 2015
Discipline: Clinical Sciences
Professor Andrew Biankin

Regius Professor of Surgery and Director, Wolfson Wohl Cancer Research Centre

Professor Andrew Biankin is a leading expert in pancreatic cancer and heads a scientific program focused on developing personalised medicine strategies through his role in the International Cancer Genome Consortium and UK-wide initiatives. His work includes defining the molecular pathology of pancreatic cancer and its precursor lesions and defining novel treatment strategies based on this knowledge with academic and industry partners. Andrew plays key roles in enhancing clinical development and health care policy and practice through government and industry.